Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U... Show more
Nomura Holdings, Inc. (NMR) is a leading Japanese financial services firm offering a broad range of products including retail brokerage, wealth management, investment banking, wholesale services, and asset management to individual, corporate, and institutional clients globally. Headquartered in Tokyo, Nomura operates through three main segments: Retail, Wholesale, and Merchant Banking, with significant exposure to global markets, particularly in Asia, Europe, and the U.S. Its business model relies on fee-based revenues from advisory, underwriting, trading, and asset management, alongside net interest income (NII, earnings from lending minus funding costs). In a competitive landscape dominated by global giants like JPMorgan and Goldman Sachs, Nomura differentiates through its strong Asian footprint and wealth management growth, which has bolstered fundamentals amid recent stock price movements tied to trading volatility and earnings cycles.
Over the last 30 days, NMR stock moved from a close of $8.00 on March 25 to $7.87 on April 24, marking a -1.6% decline. The period was volatile and range-bound, dipping to $7.58 in late March before rallying to $8.75 mid-April, then falling sharply.
In the past quarter, shares dropped -13.0% from $9.04 on January 26 to the current $7.87, after peaking at $9.58 in mid-February. The trend was downward overall, with steady declines in March punctuated by an April rebound that faded recently, reflecting trend-driven corrections amid elevated volume during swings.
NMR's 30-day price movement stemmed primarily from earnings anticipation and company-specific actions amid financial sector volatility. Shares bottomed near $7.40 in mid-March before climbing on April 14 news of a substantial share buyback and cancellation program, tightening the equity base and signaling confidence. This propelled a rally to $8.75 by April 16. However, momentum stalled as investors awaited Q4 results, released April 24, which revealed a 19% Q4 net income drop to ¥73.9 billion despite 27% YoY revenue growth to ¥577.2 billion, due to higher expenses and impairments—triggering today's decline. Analyst sentiment remained mixed, with no major upgrades, while broader yen strength pressured trading desks.
The quarterly downturn reflected sustained pressures from earlier profit warnings and macroeconomic headwinds. Post-Q3 earnings in late January (EPS $0.20 miss), shares rallied to a February peak before dropping on disclosed crypto-related losses and European trading setbacks. March saw further weakness amid Japan financial sector trends, including BOJ rate hike impacts on NII and global equity selloffs. Institutional flows shifted cautiously, with Nomura's wholesale segment facing competition. Cumulative effects included volatile trading revenues sensitive to market trends, though record full-year results (net income up 6% to ¥362.1 billion, ROE (return on equity) at 10.1%) provided some support via wealth management strength.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-driven trading bots from a library of hundreds scanning thousands of tickers like NMR. These bots employ diverse strategies—such as momentum, mean reversion, or pattern recognition—across various timeframes, from intraday to long-term swings. Performance metrics highlight win rates, average returns, and drawdowns, with only the most relevant and consistently strong bots featured based on recent market conditions. This curated selection helps traders identify tools aligned with current stock analysis and price movements in financials. Explore the page to discover bots potentially suited for monitoring NMR's volatility and integrating into your trading toolkit.
Key factors for NMR include upcoming macroeconomic developments like Bank of Japan (BOJ) policy shifts, which could boost NII but pressure trading if yen appreciates further. Monitor global interest rates and equity volatility impacting wholesale revenues. Company catalysts encompass execution of the ongoing share repurchase, wealth management client inflows, and M&A (mergers and acquisitions) activity in investment banking. Risks involve regulatory scrutiny in international ops and impairment charges; positive triggers may arise from sustained record profitability trends. Track sector peers and institutional ownership for sentiment shifts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
NMR moved above its 50-day moving average on May 29, 2026 date and that indicates a change from a downward trend to an upward trend. In of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where NMR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NMR advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 270 cases where NMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for NMR moved out of overbought territory on June 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on July 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NMR as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for NMR turned negative on June 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
NMR broke above its upper Bollinger Band on June 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.147) is normal, around the industry mean (4.088). P/E Ratio (12.225) is within average values for comparable stocks, (48.334). NMR's Projected Growth (PEG Ratio) (0.815) is slightly lower than the industry average of (1.857). Dividend Yield (0.036) settles around the average of (0.034) among similar stocks. P/S Ratio (2.402) is also within normal values, averaging (32.214).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company with interests in financial services
Industry InvestmentBanksBrokers